Collegium Pharmaceutical (COLL) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Collegium Pharmaceutical (COLL) over the last 7 years, with Sep 2025 value amounting to $0.84.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted) rose 211.11% to $0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.61, marking a year-over-year decrease of 30.60%. This contributed to the annual value of $1.86 for FY2024, which is 44.19% up from last year.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted) amounted to $0.84 in Q3 2025, which was up 147.06% from $0.34 recorded in Q2 2025.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted)'s 5-year high stood at $1.79 during Q2 2021, with a 5-year trough of -$0.73 in Q4 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is $0.39, with a median of $0.36 in 2024.
- Per our database at Business Quant, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) slumped by 465.00% in 2021 and then spiked by 5,200.00% in 2023.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.73 in 2021, then spiked by 71.23% to -$0.21 in 2022, then spiked by 490.48% to $0.82 in 2023, then slumped by 56.10% to $0.36 in 2024, then soared by 211.11% to $0.84 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.84 for Q3 2025, versus $0.34 for Q2 2025 and $0.07 for Q1 2025.